|

The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)

RECRUITINGSponsored by University of Bern
Actively Recruiting
SponsorUniversity of Bern
Started2020-03-02
Est. completion2030-12
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04611516

Summary

The Ear-Nose-Throat (ENT) Prospective International Cohort of patients with Primary Ciliary Dyskinesia (EPIC-PCD) is a prospective observational clinical cohort study, set up as a multinational multi-centre study. It is embedded into routine patient care of participating reference centres for PCD and patients keep being managed according to local procedures and guidelines.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Diagnosis of PCD (clinical and test certified)
* Patient must undergo an ENT examination minimum once a year as part of their clinical follow-up

Exclusion Criteria:

None

Conditions3

Heart DiseaseKartagener SyndromePrimary Ciliary Dyskinesia

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.